Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...

Shares of Arcutis Biotherapeutics, Inc. (ARQT) have gained 0.8% over the past four weeks to close the last trading session at $12.78, but there could still be a solid upside left in the stock if short ...

A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BridgeBio Pharma (BBIO – Research Report) and ...

Calidi Biotherapeutics, Inc., a biotechnology company specializing in biological products, has increased its stock offering capacity under its existing Sales Agreement with Ladenburg Thalmann & Co.

Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares closed lower on Monday potentially following the company's announcement of Dan Kirby as Chief Commercial Officer.

Sensei Biotherapeutics (SNSE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE ...